FOXK2 and hepatocellular carcinoma: Moreover, FOXK2, one of the two members of FOXK family, which collaborated with FOXK1 and showed the similar capability in a few physiological and pathological processes (19, 20, 33), has been demonstrated to change the phosphorylated status of AKT and exert oncogenic function in hepatocellular carcinoma (34).